Korro Bio Inc. (KRRO)
NASDAQ · Healthcare
Korro Bio Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Korro Bio Inc. shareholder equity for the quarter ending December 31, 2025 were 51.4M, a 67.93% decrease year-over-year.
- Korro Bio Inc. shareholder equity for 2025 were 51.4M, a 67.93% decrease from 2024.
- Korro Bio Inc. shareholder equity for 2024 were 160.4M, a 5.59% decrease from 2023.
- Korro Bio Inc. shareholder equity for 2023 were 169.9M, a 271.57% decrease from 2022.
- Korro Bio Inc. shareholder equity for 2022 were -99.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Korro Bio Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $51 |
| 2024 | $160 |
| 2023 | $170 |
| 2022 | $-99 |
| 2021 | $-42 |
| 2020 | $192 |
| 2019 | $167 |
| Korro Bio Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $51 |
| 2024-12-31 | $160 |
| 2023-12-31 | $170 |
| 2022-12-31 | $-99 |
| 2021-12-31 | $-42 |
| 2020-12-31 | $192 |
| 2019-12-31 | $167 |
Korro Bio Inc. Shareholder Equity — FAQ
Korro Bio Inc. (KRRO) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KRRO's shareholder equity history?
The chart and table above show Korro Bio Inc.'s shareholder equity by year and by quarter, including the growth rate.